Company Quick10K Filing
IGS Capital
10-K 2017-12-31 Filed 2018-05-17
10-Q 2017-09-30 Filed 2017-12-29
10-Q 2017-06-30 Filed 2017-08-11
10-Q 2017-03-31 Filed 2017-05-12
10-K 2016-12-31 Filed 2017-03-31
10-Q 2016-09-30 Filed 2016-10-28
10-Q 2016-06-30 Filed 2016-08-19
10-Q 2016-03-31 Filed 2016-06-13
10-K 2015-12-31 Filed 2016-06-10
10-Q 2015-09-30 Filed 2016-06-08
10-Q 2015-06-30 Filed 2016-06-08
10-Q 2015-03-31 Filed 2016-06-08
10-K 2014-12-31 Filed 2016-06-06
10-Q 2014-09-30 Filed 2016-06-02
10-Q 2014-09-30 Filed 2016-06-02
10-Q 2014-06-30 Filed 2016-06-02
10-K 2013-12-31 Filed 2016-05-25
10-Q 2013-06-30 Filed 2016-05-23
10-Q 2013-06-30 Filed 2016-05-23
10-K 2012-12-31 Filed 2016-04-27
10-Q 2012-09-30 Filed 2016-01-21
10-Q 2012-09-30 Filed 2016-01-21
10-Q 2012-06-30 Filed 2016-01-21
10-K 2011-12-31 Filed 2013-06-07
10-Q 2011-09-30 Filed 2013-02-11
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-03-31 Filed 2011-05-16
10-K 2010-12-31 Filed 2011-03-31
10-Q 2010-09-30 Filed 2010-11-15
10-Q 2010-08-13 Filed 2010-08-13
10-Q 2010-03-31 Filed 2010-05-17
10-K 2009-12-31 Filed 2010-03-31
8-K 2018-11-26
8-K 2018-11-05
8-K 2018-08-03
8-K 2018-03-29
8-K 2018-03-26
8-K 2018-01-15

IGS Capital Financials

IGSC Metrics, Comps, Filings

Quarterly | Annual

Valuation ($)

Market Cap, Enterprise Value

Balance Sheet ($)

Assets, Equity

Income Statement ($ Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($ Quarterly)

Ops, Inv, Fin

Comps ($ TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI) 0% 1,546,418,000,000 322,654,000,000 0 0 0 0 -853,740,002,000
1 800 Flowers Com (FLWS) 944,323,920,000 42% 13.3 6% 664,955,000,000 335,559,000,000 1,266,390,000,000 533,727,000,000 36,761,000,000 75,090,000,000 1,000,931,920,000
10x Genomics (TXG) 4,804,979,012,000 75% -490.3 -2% 572,815,000,000 151,367,000,000 61,207,000,000 45,727,000,000 -9,603,000,000 -8,887,000,000 4,357,180,012,000
12 Retech (RETC) 0 32% -0.1 -1,385% 1,118,250,000 20,421,127,000 625,058,000 198,665,000 -15,490,613,000 -14,800,308,000 965,755,000
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH) 33,710,970,000 0% 0.4 -5% 164,088,000,000 108,405,000,000 18,194,000,000 0 -7,969,000,000 -8,017,000,000 -2,855,031,000
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH) 25% -2.4 -15% 18,526,563,000 23,194,425,000 27,219,092,000 6,699,091,000 -2,862,088,000 -1,433,089,000 3,396,276,000
1895 Bancorp of Wisconsin (BCOW) 46,152,714,600,000 12,508.1 -0% 441,187,000,000 382,722,000,000 0 0 -44,000,000 3,689,000,000 46,142,358,599,000
1st Constitution Bancorp (FCCY) 164,503,502,000 0% 4.4 1% 1,342,565,000,000 1,204,038,000,000 490,000,000 0 13,787,000,000 32,503,000,000 143,747,501,000
1st Franklin Financial (FFC) 3,551,300,000 -0.6 7% 905,106,632,000 644,730,289,000 0 0 62,078,000,000 80,003,852,000 -45,962,064,000
24 7 Kid Doc (TVMD)
1st Source (SRCE) 1,200,032,698,000 7.9 1% 6,691,070,000,000 5,858,028,000,000 0 0 70,061,000,000 136,342,000,000 1,072,547,697,000
2050 Motors (ETFM) 0 -0.2 -166,272,400% 1,000 1,848,976,000 0 0 -1,662,724,000 -1,654,247,000 250,018,000
21Vianet Group (VNET) 6,005,115,957,000 0% 11,150,717,000,000 5,787,533,000,000 0 0 0 0 3,344,094,956,000
22nd Century (XXII) 301,854,194,000 1% -14.1 -36% 61,864,260,000 6,554,256,000 25,705,508,000 304,468,000 -22,432,825,000 -21,464,093,000 301,825,770,000
1Life Healthcare (ONEM)

Balance Sheet ($)2011-09-302011-12-312012-06-302012-09-302012-12-312013-03-312013-06-302013-12-312014-06-302014-09-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-30
Cash5,866,305,0000000000000000000000031,182,000
Accounts Receivable959,765,0000467,000
Inventory00
PP&E704,641,000035,901,000
Assets9,732,165,000031,487,000010,498,00010,102,0009,358,0004,829,0000000000000000238,781,000588,290,000
Accounts Payable444,316,00004,940,000
Long-Term Debt
Liabilities8,606,642,000205,067,000239,066,000206,067,000134,328,00091,319,000109,023,00077,935,000109,693,00091,810,000127,576,000146,771,000165,227,000183,520,000201,543,000220,918,000196,675,00077,512,00093,473,000102,110,000110,888,000121,799,000281,094,000
Stockholders' Equity864,302,000-205,067,000-207,579,000-206,067,000-123,830,000-81,217,000-99,665,000-73,106,000-109,693,000-91,810,000-127,576,000-146,771,000-165,227,000-183,520,000-201,543,000-220,918,000-196,675,000-77,512,000-93,473,000-102,110,000-110,888,000116,982,000307,196,000
Income Statement ($)2011-09-302011-12-312012-06-302012-09-302012-12-312013-03-312013-06-302013-12-312014-06-302014-09-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-30
Revenue2,032,426,000-9,005,196,0000000000000000000000024,135,000
Cost of Revenue1,978,933,000-6,226,338,00000018,729,000
Gross Profit53,493,000-2,778,858,0000005,406,000
R&D
SG&A8,521,009,000-10,090,461,0001,512,0001,000,000133,224,00017,387,00018,448,00017,883,00018,704,00017,883,00019,195,00018,456,00018,293,00018,023,00019,375,00018,987,00042,058,00015,961,0008,637,0008,778,00063,143,00060,616,000
Tax7,965,000-11,055,0000000000000000000000
Net Income-6,477,790,000-791,528,000-1,512,0000-97,172,000-17,387,000-18,448,000-21,581,000-17,883,000-18,704,000-17,883,000-18,456,000-18,293,000-18,023,000-17,757,000-42,058,000-15,961,000-8,637,000-8,778,000-45,721,000-41,727,000
Cash Flow ($)2011-09-302011-12-312012-06-302012-09-302012-12-312013-03-312013-06-302013-12-312014-06-302014-09-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-30
Cash Operating-6,575,766,0000000000000-42,000,000-73,767,000-16,758,000-7,159,000-7,443,000-19,192,000
Cash Investing100,346,000000000000
Cash Financing577,993,000000000000042,000,00073,767,00016,758,0007,443,00019,205,000480,125,000